Clinical trial
New perSEPtion. New Patient's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based RRMS Treatments.
NCT06127095 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New perSEPtion. New Patient's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based RRMS Treatments.
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 24, 2023
- Completion date
- November 28, 2024
- Enrollment
- 474 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.